EMAIL DETAILS

Linda,

Would you like further edits to this document so that it can be shared with staff or are you comfortable with the current document being shared with Sen. Murray’s Chief of Staff?

Let us know and Hunter and I can certainly help edit it down if you want.

Thanks,

Eric


Eric D. Schwerin
Rosemont Seneca Advisors, LLC
1010 Wisconsin Ave., NW
Suite 705
Washington, DC 20007
(202) 333-1880
eschwerin@rosemontseneca.com <x-msg://59/eschwerin@obblaw.com>
P Consider the environment before printing this email.

> On Mar 30, 2016, at 5:18 PM, Hunter Biden <hbiden@rosemontseneca.com> wrote:
>
> Linda,
> Thank you for this. I'm cc'ing my business partner, Eric Schwerin, who can also give some input/suggested edits. In regards to the sensitivity of this document, you may want to provide us with a sanitized version. Sen. Murray is not in town right now so we won't be able to physically give it to her, plus she will likely turn around and give it to her staff anyways. In the interest of time, we were planning to approach her chief of staff with this, so if you would prefer that we share a sanitized version with him, please send me that.
>
> Thanks for keeping me posted about the FDA reply.
>
> Best,
> Hunter
>
> On Tue, Mar 29, 2016 at 10:58 PM, Linda Powers <lpowers@nwbio.com <mailto:lpowers@nwbio.com>> wrote:
> Dear Hunter:
>
>
>
> Attached is a shortened version. As you will see, we have cut about 2/3 of a page of text and eliminated a number of the secondary points from the story. It is now less than 2 pages, but not quite down to 1-1/2 pages. Please take another look and let us know if this will do. If you think it still needs to be shorter, it would be great if you could suggest (with fresh eyes) what to cut.
>
>
>
> IMPORTANT NOTE: This paper tells the true and unvarnished facts. As such, it is ultra ultra sensitive. If this paper were to fall into the wrong hands, it could lead to severe repercussions for NW Bio. So, please only give the paper in PDF format and please only to Patty herself – not her staff. If that’s not possible, and you have to give it to her staff, please tell us before you give it to them, and we will make a sanitized version.
>
>
>
> FYI, we submitted our reply letter to FDA today, requesting a formal in-person meeting with us and our independent experts. It will be interesting to see whether FDA grants us the meeting (which is absolutely the normal thing to do)…. or refuses to meet with us, as the DMC did last summer….
>
>
>
> Thanks again for your help. Kind regards,
>
>
>
> Linda
>
>
>
> From: Linda Powers
> Sent: Tuesday, March 29, 2016 4:09 PM
> To: 'Hunter Biden'
> Cc: Les Goldman
> Subject: RE: NW Bio completed 1-pager...
>
>
>
> Dear Hunter:
>
>
>
> Thanks very much for your feedback. Appreciate it. We literally just filed our reply letter with FDA (at 3:58 pm!... ahead of 4 pm cutoff). So, now we can turn back to this memo and take another crack at shortening it. Do you have any suggestions about what to cross out? We will aim to get a reduced version back to you this evening.
>
>
>
> Kind regards,
>
>
>
> Linda
>
>
>
> From: Hunter Biden [mailto:hbiden@rosemontseneca.com <mailto:hbiden@rosemontseneca.com>]
> Sent: Tuesday, March 29, 2016 3:40 PM
> To: Linda Powers
> Cc: Les Goldman
> Subject: Re: NW Bio completed 1-pager...
>
>
>
> Dear Linda,
>
> Thank you for putting this together. I think it is really important to get this down to no more than 1 1/2 pages. My suggestion would be to stick with the key issue and request for this 1-pager as you will have other opportunities to expand on the background later down the road. Let me know when you have an idea of timing for turning this around. Thanks again.
>
>
>
> Best,
>
> Hunter
>
>
>
> On Mon, Mar 28, 2016 at 11:41 PM, Linda Powers <lpowers@nwbio.com <mailto:lpowers@nwbio.com>> wrote:
>
> Dear Hunter:
>
>
>
> Attached is the completed draft of the “1-pager”…. which is actually 2 pages. We really struggled to make it as tight as possible, but ther is so much key information that we just did not get it into 1 page. If you read it with fresh eyes and see how it can be cut down from 2 pages, suggested edits to do so would be welcome.
>
>
>
> If you think it’s OK at a length of 2 pages, then let’s put our heads together about how best to send it out the door. Thanks!
>
>
>
> Kind regards,
>
>
>
> Linda
>
>
>
> From: Linda Powers
> Sent: Monday, March 28, 2016 6:17 PM
> To: 'hbiden@rosemontseneca.com <mailto:hbiden@rosemontseneca.com>'
> Cc: Les Goldman
> Subject: RE: Quick update: we're working on the 1-pager
>
>
>
> Hi Hunter:
>
>
>
> We have been working all day with the statisticians in regard to the updated data (still on a blinded basis). We just got off a conf call with them, receiving the data and…. it is excellent! Would you like to hear it (under our CDA)? We can give you a quick call. [?]
>
>
>
> Attached is the mostly-but-not-completely finished 1-pager that I drafted during the weekend. It was devilishly difficult to make it tight enough. Comments welcome. I’m about to turn back to finishing the last 2 points as noted in the paper.
>
>
>
> We have not reached out to Chris yet but plan to do so first thing in the morning, now that we have the update data and we know that it’s good.
>
>
>
> Kind regards,
>
>
>
> Linda
>
>
>
> From: hbiden@rosemontseneca.com <mailto:hbiden@rosemontseneca.com> [mailto:hbiden@rosemontseneca.com <mailto:hbiden@rosemontseneca.com>]
> Sent: Monday, March 28, 2016 5:43 PM
> To: Linda Powers
> Cc: Les Goldman
> Subject: Re: Quick update: we're working on the 1-pager
>
>
>
> Any progress on this? Have you reached out to Chris Boies?
>
> RHB
>
> 202-333-1880 <tel:202-333-1880>
>
> On Mar 25, 2016, at 12:18 PM, Linda Powers <lpowers@nwbio.com <mailto:lpowers@nwbio.com>> wrote:
>
> Hi Hunter:
>
>
>
> Just a quick update to let you know that we’re working on the 1-pager. Last night and this morning, we’ve been working intensively on obtaining some key info for the 1-pager, as well as tied up in calls with our Board members. We hope to have the 1-pager to you in the next hour or so.
>
>
>
> Thanks SO much for your help! We are really grateful.
>
>
>
> Kind regards,
>
>
>
> Linda
>
>
>
>
>
>
> --
>
> R. Hunter Biden
>
> Rosemont Seneca Partners, LLC
> 1010 Wisconsin Ave., NW
> Suite 705
> Washington, DC 20007
> (202) 333-1880 <tel:%28202%29%20333-1880>
>
>
> --
> R. Hunter Biden
> Rosemont Seneca Partners, LLC
> 1010 Wisconsin Ave., NW
> Suite 705
> Washington, DC 20007
> (202) 333-1880